Routine Versus Selective Ureterolysis During Total Laparoscopic Hysterectomy for Benign Conditions
1 other identifier
interventional
100
1 country
1
Brief Summary
To evaluate whether routine ureterolysis during Total Laparoscopic Hysterectomy for benign gynecologic conditions affects operative efficiency and perioperative safety compared with a selective ureterolysis approach.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 16, 2026
CompletedFirst Posted
Study publicly available on registry
August 19, 2026
CompletedStudy Start
First participant enrolled
August 21, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 28, 2027
August 19, 2026
August 1, 2026
6 months
August 16, 2026
August 16, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Total operative duration
Total operative duration in minutes measured from skin incision to skin closure
day 0
Secondary Outcomes (1)
time needed for ureterolysis
day 0
Study Arms (2)
Routine Ureterolysis
EXPERIMENTALIntervention Group: Routine Ureterolysis
Selective Ureterolysis
ACTIVE COMPARATORControl group: selective Ureterolysis
Interventions
for all cases of the group: After entering the pelvis and before uterine vessel ligation, routine bilateral ureterolysis will be performed. The retroperitoneal space will be opened by incising the peritoneum overlying the ureter, followed by careful blunt and sharp dissection to identify each ureter and trace its course from the pelvic brim toward the uterine artery and ureteric tunnel. Surrounding tissue will be dissected only to the extent necessary to obtain clear visualization and safe lateralization of the ureter before completing the hysterectomy. Excessive skeletonization, thermal spread, and disruption of the ureteral blood supply will be avoided. The procedure will be performed using a standardized technique and documented in the operative record.
for selected cases of the group: After entering the pelvis and before uterine vessel ligation, routine bilateral ureterolysis will be performed. The retroperitoneal space will be opened by incising the peritoneum overlying the ureter, followed by careful blunt and sharp dissection to identify each ureter and trace its course from the pelvic brim toward the uterine artery and ureteric tunnel. Surrounding tissue will be dissected only to the extent necessary to obtain clear visualization and safe lateralization of the ureter before completing the hysterectomy. Excessive skeletonization, thermal spread, and disruption of the ureteral blood supply will be avoided. The procedure will be performed using a standardized technique and documented in the operative record.
Eligibility Criteria
You may qualify if:
- Women aged 35-70 years
- Scheduled for TLH for benign indications:
- Symptomatic fibroids, Abnormal uterine bleeding, Adenomyosis, Endometrial hyperplasia, Pelvic organ prolapse requiring hysterectomy, Chronic pelvic pain, Uterine size ≤16 weeks
You may not qualify if:
- Previous pelvic radiation
- Known ureteric abnormalities or pathology
- Severe cardiopulmonary disease precluding laparoscopy
- Inability to provide informed consent
- Known retroperitoneal pathology
- Emergency surgery
- Uterine size \> 16 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ClinAmygatelead
Study Sites (1)
Kasr Alaini gynecology and obstetrics hospital
Cairo, Cairo Governorate, 11472, Egypt
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants and postoperative outcome assessors will be blinded to treatment allocation. Because of the nature of the surgical interventions, the operating surgeons cannot be blinded. Data analysts will remain blinded to group allocation, with the intervention groups coded and their identities concealed until the primary analysis has been completed.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant lecturer
Study Record Dates
First Submitted
August 16, 2026
First Posted
August 19, 2026
Study Start
August 21, 2026
Primary Completion (Estimated)
February 28, 2027
Study Completion (Estimated)
April 28, 2027
Last Updated
August 19, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share